ILiAD Biotechnologies Strengthens Leadership Team With Veteran Vaccine Executives as BPZE1 Advances Toward Late-Stage Development ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical-stage biotechnology company focused on developing innovative approaches to prevent and treat diseases caused by Bordetella pertussis, has announced…
ImmunityBio Appoints Global Health Leader Dr. Jim Yong Kim as Vice Chairman to Strengthen International Partnerships and Expand Global Healthcare Access ImmunityBio, Inc., a commercial-stage biotechnology company focused on developing and delivering immunotherapy-based treatments, has announced the appointment of Dr.…
Diabetes and Metabolism Specialists Improves Patient Engagement and Chronic Care Management with eClinicalWorks Digital Solutions eClinicalWorks®, a leading ambulatory cloud electronic health record (EHR) provider, announced that Diabetes and Metabolism Specialists, a high-volume endocrinology practice, has achieved significant operational and…
Clinilabs Strengthens Executive Leadership with the Appointments of Dr. Bob Dagher as Chief Medical Officer and Dr. Waqar Ahmed Siddiqui as Principal Investigator Clinilabs LLC, a global full-service contract research organization (CRO) specializing in the development of therapies for central…
Synthekine Appoints Biotechnology Veteran Dr. Susan M. Molineaux as CEO to Lead Next Phase of Oncology Drug Development Synthekine, Inc., a clinical-stage biotechnology company focused on developing precision cytokine therapeutics for cancer and immune-mediated diseases, has announced the appointment of…
Mosaic Therapeutics Strengthens Leadership with Appointment of Dr. Allison Jeynes as Board Chair to Drive Clinical Growth Mosaic Therapeutics, a biotechnology company focused on developing innovative targeted combination therapies for hematological and solid cancers, has announced the appointment of Dr.…
Spruce Biosciences Appoints Dr. Jessica Cohen Pfeffer as Vice President of Clinical Development to Advance Rare Neurological Disease Pipeline Spruce Biosciences, Inc., a late-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for neurological disorders with significant unmet medical…
Korsana Biosciences Strengthens Executive Leadership as KRSA-028 Advances Toward Clinical Development for Alzheimer’s Disease Korsana Biosciences, Inc., a biotechnology company focused on discovering and developing innovative therapies for neurodegenerative disorders, has announced a series of strategic leadership appointments designed to…
Polpharma Biologics Advances PB016 as FDA and EMA Accept Biosimilar Applications for Review Polpharma Biologics International AG has announced a significant regulatory milestone with the acceptance of both its Biologics License Application (BLA) by the U.S. Food and Drug Administration…
Bayer Submits New Drug Application in China to Expand Finerenone Use for Adults with Non-Diabetic Chronic Kidney Disease Bayer has announced the submission of a New Drug Application (NDA) to the Center for Drug Evaluation (CDE) of China’s National Medical…
EU Approval Positions Datroway® as the Only TROP2-Targeted Therapy with Overall Survival Benefit in First-Line Metastatic TNBC The European Commission (EC) has approved Datroway® (datopotamab deruxtecan) as a monotherapy for the first-line treatment of adults with unresectable or metastatic triple-negative…
Polpharma Biologics’ Vedolizumab Biosimilar PB016 Accepted for FDA and EMA Review, Advancing Access to Biologic Therapy for Inflammatory Bowel Disease Polpharma Biologics International AG has announced that its proposed vedolizumab biosimilar, PB016, has reached an important regulatory milestone after both…